Proteomics - Market Insights, Competitive Landscape, and Market Forecast - 2030

The global proteomics market is estimated to grow at a CAGR of 13.54% during the forecast period from 2024 to 2030. The proteomics market is observing significant market growth primarily due to the growing demand for personalized medicines to treat various chronic or targeted diseases. Further, the increasing need for advanced diagnostics in targeted disease treatment, the high prevalence of various target diseases such as cancer, cardiovascular diseases (CVDs), respiratory diseases, and chronic kidney diseases (CKD) across the world, and the increasing focus on product usage in drug designing, biomarker discoveries, and clinical diagnostics for the diagnosis and treatment of diseases will create the need for proteomics in the market. Additionally, the increasing product and service launches and approvals, the presence of key players in the market, and other factors will create a requisite for proteomics in the market. Lastly, the increasing overall healthcare sector, drug discovery, and surging investments by key players in the healthcare industry will in turn increase the research & developmental activities, ultimately affecting the demand certainly. Therefore, the market of proteomics is estimated to grow at a substantial CAGR during the forecast period from 2024 to 2030.

Proteomics Market Dynamics:

One of the key aspects driving the proteomics market is the rising prevalence of various chronic diseases such as cancer, cardiovascular diseases, and others.

For instance, according to the World Health Organization (WHO) 2022, cancer is a leading cause of death worldwide, accounting for nearly 10 million deaths in 2020. The new cases of breast cancer in 2020 were 2.26 million cases, across the globe. The same source stated that lung cancer accounted for 2.21 million new cases, colon and rectum cancer for 1.93 million new cases, prostate cancer with 1.41 million new cases, skin cancer accounted for 1.20 million new cases, and stomach cancer new cases were 1.09 million in 2020, globally. Further, according to WHO 2022, cardiovascular diseases (CVDs) are the leading cause of death globally, taking an estimated 17.9 million lives each year.

Thus, owing to the increasing prevalence of various life-threatening diseases and increasing demand for personalized therapies resulting in a positive impact on the market of proteomics as proteomics holds great promise in contributing to the prevention and cure of cancer because it provides unique tools for the discovery of biomarkers and therapeutic targets. Therefore, the increasing prevalence of chronic diseases will increase the demand for personalized medicine, eventually leading to an increased demand for proteomics in the market.

The increasing investments in proteomics R&D are one of the prominent growth drivers of the proteomics market. In 2022, the National Institutes of Health (NIH) of the United States provided USD 45 billion for medical research. This funding was intended to support life sciences research that sought to understand the fundamental processes by which diseases develop, such as the identification of biomarkers that indicate the presence of disease or the identification of the gene/protein responsible for the disease. Also, in 2020, Novo Nordisk Foundation was awarded the University of Copenhagen grant of up to USD 1.5 million to establish a mass spectrometry facility, which is a significant step forward in protein research. Thus, such investments and funding by the government and key players across the globe will increase the research & developmental activities, which in turn will affect the market of proteomics.

Further, rising healthcare costs, growing demand for tailored medication, and rising rates of genetic illnesses will increase the demand for proteomics during the forecast period.

Therefore, the factors stated above collectively will drive the overall proteomics market during the forecast period from 2024-2030.

However, the high cost of instruments, the presence of ambiguous regulatory framework, and others may prove to be challenging factors for the proteomics market growth.

The proteomics market was positively impacted during the period of the COVID-19 pandemic. During the initial stage of the pandemic, the demand for proteomics instruments and services suffered a downfall owing to the imposition of strict lockdown rules, and disruption in manufacturing, and supply. However, the proteomics techniques and instruments were used in the development of the COVID-19 vaccine to research the biomarker for vaccine development. Moreover, the proteomic approach was well suited for studying COVID-19 since it can provide quantitation and differential expression of proteins and their post-translational modifications. Thus, as the research for the COVID-19 vaccine increases, the demand for proteomics instruments and services upsurges considerably. Likewise, with the ease of lockdown restrictions, the upturn of resources and supply chain, the administration of a vaccine to the public, and with the increasing demand of proteomics for research & development activities, the demand for proteomics increases and is anticipated to do the same during the forecast period from 2022 - 2028.

Proteomics Market Segment Analysis:

Proteomics Market by Product & Services (Instrumentation Technology [Spectroscopy, Chromatography, Electrophoresis, Protein Microarrays, X-Ray Crystallography, and Other], Reagents & Consumables, and Software & Services), Application (Clinical Diagnostics, Drug Discovery, and Others), End-User (Hospitals, Clinical Laboratories, Pharmaceutical Companies, and Others), and Geography (North America, Europe, Asia-Pacific, and Rest of the World).

In the product type segment of the proteomics market, the electrophoresis segment is expected to have a significant revenue share in the year 2023. This was primarily owing to the rising availability of technologically advanced instrumentation in the market, rising instrument launches and approvals in the market, and rising demand for electrophoresis in research & developmental activities.

Electrophoresis is one of the most conventional techniques used in biotechnology, which separates the particles based on the charge and size they possess. This technology can be used for the diagnosis of various diseases, DNA sequencing, analysis of antibodies and steroids, and other medical research activities. Moreover, the electrophoresis technique is used to identify many proteins that are significant for improved characterization of tumor progression and molecular specificity of both lung cancer subtypes. As a result of electrophoresis, it is possible to distinguish proteins from tumor cells, which aids in tumor diagnosis and may contribute to the segment's growth.

Further, various other strategic steps taken by the key players in the market will help in increasing the demand for electrophoresis. For instance, in September 2020, miniPCR bio launched GELATO, a gel electrophoresis system, a type of electrophoresis with an integrated blue light with transillumination technology, allowing simultaneous nucleic acid separation.

Therefore, owing to the above-mentioned factors, the demand for electrophoresis rises, thereby the category is expected to witness considerable growth eventually contributing to the overall growth of the global proteomics market during the forecast period.

North America is expected to dominate the overall Proteomics Market:

Among all the regions, North America is expected to dominate global proteomics in the year 2023 and is expected to do the same during the forecast period from 2024-2030.

This can be ascribed to the increasing need for advanced diagnostics in targeted disease treatment, the rising prevalence of target diseases across the world, and the presence of key market players in the region are the key reasons which act as a supportive factor for the North America proteomics market growth.

For instance, according to the Cancer Facts & Figures 2022, in 2022, there will be an estimated 1.9 million new cancer cases diagnosed and 609,360 cancer deaths in the United States. The increasing incidence of cancer in the region will increase the demand for proteomics as the instrumentation is employed in the detection of tumors in a patient.

Additionally, the increasing number of novel and next-generation therapeutics approved in the region will increase the demand for proteomics. Also, the rising investments in the field of personalized medicine, the presence of globally leading market players, increasing research in the fields of omics, and the rising investments in the area of structure-based drug design will in turn increase the demand for proteomics in the North America.

Further, increasing product launches of various technologically advanced proteomics instrumentations and strategic steps such as collaboration, acquisition, and partnership by key players in the region will ultimately increase its demand. For instance, in March 2022, Thermo Fisher Scientific, the world leader in serving science, and Protein Metrics, a developer of world-class software tools for protein characterization, entered into a non-exclusive co-marketing agreement to provide advanced mass spectrometry data processing and analysis capabilities to drive innovation across the full spectrum of biopharmaceutical and proteomics applications, from research and development to quality control.

Therefore, the interplay of the aforementioned factors would provide a conducive growth environment for the North American region in the proteomics market.

Proteomics Market Key Players:

Some of the key market players operating in the proteomics market include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Danaher., General Electric Company, Bruker, Merck KGaA, Promega Corporation., Waters Corporation., Illumina, Inc., Creative Proteomics., VProteomics, HORIBA, Ltd., Applied Biomics., Fios Genomics., and others.

Recent Developmental Activities in the Proteomics Market:

• In January 2022, PreOmics GmbH, a Martinsried, Germany-based developer of innovative automation and sample preparation tools and consumables for unbiased, deep proteomics analysis by mass spectrometry, raised €13.5m in a Series B financing round provided by Bruker Corporation.
• In August 2022, Bruker Corporation, announced the launch of the new nanoElute® 2 nano-LC, of MetaboScape® and TASQ® 2023 software supporting fluxomics, and of the latest advances in PaSER™’s intelligent acquisition to enhance research in protein-protein interactions (PPIs) and metaproteomics applications.
• In February 2020, Applied Biomics, Inc., a leading Proteomics service provider, added an HCP profiling analysis using their well-established high-resolution, large format 2-Dimensional Differential In-Gel Electrophoresis (2D DIGE) platform.

Key Takeaways from the Proteomics Market Report Study

• Market size analysis for current proteomics market size (2023), and market forecast for 6 years (2024-2030)
• The effect of the COVID-19 pandemic on this market is significant. To capture and analyze suitable indicators, our experts are closely watching the Proteomics market.
• Top key product/services/technology developments, mergers, acquisitions, partnerships, and joint ventures happened for the last 3 years
• Key companies dominating the global proteomics market.
• Various opportunities available for the other competitor in the proteomics market space.
• What are the top-performing segments in 2023? How these segments will perform in 2030.
• Which are the top-performing regions and countries in the current proteomics market scenario?
• Which are the regions and countries where companies should have concentrated on opportunities for proteomics market growth in the coming future?

Target Audience who can be benefited from this Proteomics Market Report Study

• Proteomics products providers
• Research organizations and consulting companies
• Proteomics-related organizations, associations, forums, and other alliances
• Government and corporate offices
• Start-up companies, venture capitalists, and private equity firms
• Distributors and Traders dealing in proteomics
• Various end users who want to know more about the proteomics market and the latest technological developments in the proteomics market.

Frequently Asked Questions for the Proteomics Market:

1. What is proteomics?

The study of protein structure and function is known as proteomics. Proteomics is concerned with topics such as which proteins are expressed, when and where they are expressed, what their structures are in both active and inactive states, what roles they play in cell life, and how they interact with other proteins and molecules.

2. What is the global market for proteomics?

The global proteomics market is estimated to grow at a CAGR of 13.54% during the forecast period from 2024 to 2030.

3. What are the drivers for the global proteomics market?

The proteomics market is witnessing positive market growth owing to the factors such as growing demand for personalized medicines, increasing need for advanced diagnostics in targeted disease treatment, high prevalence of target diseases across the world, increasing focus on product usage in drug designing, biomarker discoveries, and clinical diagnostics for the diagnosis and treatment of diseases, increasing product launches and approvals, presence of key players in the market, and others will create an exigency for the proteomics market.

4. Who are the key players operating in the global proteomics market?

Some of the key market players operating in the proteomics market include Agilent Technologies, Inc., Thermo Fisher Scientific, Inc., Bio-Rad Laboratories, Inc., Danaher., General Electric Company, Bruker, Merck KGaA, Promega Corporation., Waters Corporation., Illumina, Inc., Creative Proteomics., VProteomics, HORIBA, Ltd., Applied Biomics., Fios Genomics., and others.

5. Which region has the highest share of the proteomics market?

Among all the regions, North America is estimated to amass a significant revenue share in the global Proteomics market. This can be ascribed to the increasing need for advanced diagnostics in targeted disease treatment, the rising prevalence of target diseases across the world, and the presence of key market players in the region are the reasons which act as a supportive factors for the North America proteomics market growth.


This product will be delivered within 2 business days.